Atrás
33
Rango del Día
$26.21
$26.86
Rango de 52 Semanas
$8.61
$37.77
Volumen
243,953
Promedio 50D / 200D
$28.74
/
$19.64
Cierre Anterior
$26.10
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 31.2 | 0.4 |
| P/B | 2.7 | 2.9 |
| ROE % | 8.8 | 3.8 |
| Net Margin % | 5.8 | 3.9 |
| Rev Growth 5Y % | 12.2 | 10.0 |
| D/E | 0.1 | 0.2 |
Precio Objetivo de Analistas
Hold
$38.75
+46.2%
Low: $35.00
High: $42.00
P/E Futuro
23.2
EPS Futuro
$1.14
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
360 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2027 |
$1.45
$1.42 – $1.51
|
390 M | 3 |
| FY2026 |
$1.14
$1.11 – $1.17
|
360 M | 3 |
Puntos Clave
Revenue grew 12.18% annually over 5 years — strong growth
Debt/Equity of 0.07 — conservative balance sheet
Generating 40.43M in free cash flow
P/E of 31.17 — premium valuation
Cash machine — converts 211.84% of earnings into free cash flow
Capital efficient — spends only 0.72% of revenue on capex
Crecimiento
Revenue Growth (5Y)
12.18%
Revenue (1Y)12.47%
Earnings (1Y)12.54%
FCF Growth (3Y)10.07%
Calidad
Return on Equity
8.77%
ROIC9.35%
Net Margin5.79%
Op. Margin8.89%
Seguridad
Debt / Equity
0.07
Current Ratio4.03
Interest Coverage28.21
Valoración
P/E Ratio
31.17
P/B Ratio2.72
EV/EBITDA18.01
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 12.47% | Revenue Growth (3Y) | 9.58% |
| Earnings Growth (1Y) | 12.54% | Earnings Growth (3Y) | -18.19% |
| Revenue Growth (5Y) | 12.18% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 329.52M | Net Income (TTM) | 19.09M |
| ROE | 8.77% | ROA | 6.97% |
| Gross Margin | 75.17% | Operating Margin | 8.89% |
| Net Margin | 5.79% | Free Cash Flow (TTM) | 40.43M |
| ROIC | 9.35% | FCF Growth (3Y) | 10.07% |
| Safety | |||
| Debt / Equity | 0.07 | Current Ratio | 4.03 |
| Interest Coverage | 28.21 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 31.17 | P/B Ratio | 2.72 |
| P/S Ratio | 1.81 | PEG Ratio | 2.06 |
| EV/EBITDA | 18.01 | Dividend Yield | 0.00% |
| Market Cap | 594.86M | Enterprise Value | 527.37M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 329.52M | 292.98M | 274.42M | 246.79M | 208.06M |
| Net Income | 19.09M | 16.96M | 28.52M | -17.87M | -11.81M |
| EPS (Diluted) | 0.82 | 0.70 | 1.23 | -0.89 | -0.60 |
| Gross Profit | 247.70M | 216.69M | 195.13M | 175.98M | 148.21M |
| Operating Income | 29.28M | 22.18M | 18.04M | -12.76M | -1.76M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 273.94M | 297.92M | 281.44M | 255.00M | 244.27M |
| Total Liabilities | 55.04M | 81.33M | 87.80M | 133.60M | 116.04M |
| Shareholders' Equity | 218.90M | 216.60M | 193.64M | 121.40M | 128.23M |
| Total Debt | 15.96M | 45.11M | 50.38M | 72.23M | 80.61M |
| Cash & Equivalents | 83.45M | 94.37M | 61.03M | 21.93M | 28.23M |
| Current Assets | 165.17M | 177.56M | 145.29M | 119.76M | 113.55M |
| Current Liabilities | 40.96M | 40.70M | 41.06M | 64.33M | 34.46M |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#763 of 1024
Actividad Reciente
Entró
Cash Flow Compounder
Mar 24, 2026